title: The TAILOR study: to agree or to disagree?
authors.affiliation: Thoracic Oncology Unit, Grenoble University Hospital and INSERM U823, France. Electronic address: DMoro-Sibilot@chu-grenoble.fr.
authors.forename: Denis
authors.initials: D
authors.lastname: Moro-Sibilot
authors.affiliation: Statistics Department, Centre Léon Bérard, Lyon, France.
authors.forename: David
authors.initials: D
authors.lastname: Perol
authors.affiliation: Statistics Department, Centre Léon Bérard, Lyon, France.
authors.forename: Sylvie
authors.initials: S
authors.lastname: Chabaud
authors.affiliation: Pneumology Department, Hôpital Tenon, Paris, France; ER2 Paris VI University, France.
authors.forename: Jacques
authors.initials: J
authors.lastname: Cadranel
authors.affiliation: Pneumology Department, Hôpital Sainte Musse, Toulon, France.
authors.forename: Clarisse
authors.initials: C
authors.lastname: Audigier Valette
authors.affiliation: Medical Cancerology Department, Centre Léon Bérard, Lyon, France.
authors.forename: Maurice
authors.initials: M
authors.lastname: Perol
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality; D017326:Clinical Trials, Phase III as Topic; D000077143:Docetaxel; D066246:ErbB Receptors / Q000235:genetics; D000069347:Erlotinib Hydrochloride; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality; D011799:Quinazolines / Q000627:therapeutic use*; D012107:Research Design; D016879:Salvage Therapy / Q000379:methods; D043823:Taxoids / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D043823:Taxoids; D000077143:Docetaxel; D000069347:Erlotinib Hydrochloride; C512478:EGFR protein, human; D066246:ErbB Receptors
keywords: Chemotherapy; Lung cancer; Second line; Targeted therapy